[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357229-105":59,"doc-detail-357229-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","biomimetic-lapachone-and-hemin-nanoassembly-for-intracellular-oxidation-cascade-amplified-ferroptosis-in-hepatocellular-carcinoma-therapy","Biomimetic β-lapachone and hemin nanoassembly for intracellular oxidation cascade amplified ferroptosis in hepatocellular carcinoma therapy","","Ferroptosis is an important non-apoptotic programmed cell death driven by excessive iron and reactive oxygen species (ROS). Precise and potent ferroptosis induction remains challenging because it must strongly amplify lipid peroxidation and iron overload in cancer cells. The study designs a biomimetic red blood cell membrane camouflaged β-lapachone and hemin nanoassembly to induce tumor-selective ROS generation, trigger lethal lipid peroxidation, and amplify iron pools via NRF2 feedback, achieving effective therapy in cellular and animal models.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biomimetic-lapachone-and-hemin-nanoassembly-for-intracellular-oxidation-cascade-amplified-ferroptosis-in-hepatocellular-carcinoma-therapy/357229/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biomimetic-lapachone-and-hemin-nanoassembly-for-intracellular-oxidation-cascade-amplified-ferroptosis-in-hepatocellular-carcinoma-therapy/357229.png","ImageObject",300,407,{"name":92,"@type":93},"Jasmine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study address in ferroptosis-based cancer therapy?","Question",{"text":113,"@type":114},"It addresses the difficulty of achieving precise, potent ferroptosis induction with strong amplification of cellular lipid peroxidation and iron overload in cancer cells, which remains a significant hurdle.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the RBCM-camouflaged LHNPs@RBCM promote ferroptosis in hepatocellular carcinoma cells?",{"text":118,"@type":114},"After endocytosis, NQO1 converts released β-lapachone into ROS with selectivity, hemin uses H2O2 to generate hydroxyl radicals via Fenton reaction, and ROS then trigger lethal lipid peroxidation leading to ferroptosis.",{"name":120,"@type":111,"acceptedAnswer":121},"What role does the NRF2 pathway play in amplifying ferroptosis?",{"text":122,"@type":114},"ROS activates NRF2, which upregulates NQO1 and HO-1, forming a positive feedback loop that elevates H2O2 levels and labile iron pools, further strengthening ferroptosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},357229,1790160610,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Wang et al. Journal of Nanobiotechnology (2026) 24:567  \n[https://doi.org/10.1186/s12951-026-04486-z](https://doi.org/10.1186/s12951-026-04486-z)  \nJournal of Nanobiotechnology  \nRESEARCH Open Access  \nBiomimetic β-lapachone and hemin   \nnanoassembly for intracellular oxidation cascade amplified ferroptosis in hepatocellular carcinoma therapy  \nJiyue Wang1,2,3†, Yongyi Liang1,2,3†, Wenxiang Qi3,4, Wenjun Li3,4, Donglin He1,2,3, Lei Ding3, Lingjie Wu3,4, Ming Wu3,4, Yupeng Sun3,4, Yongyi Zeng3,4, Xiaolong Liu1,2,3,4*, Yao Huang3,4*, Jingfeng Liu1,2,3,4,5* and Xiaolong Zhang3,4*  \nAbstract  \nFerroptosis represents one of important no-apoptotic programmed cell death with over accumulation of ironand reactive oxygen species (ROS) . While its key role and trials for cancer therapy, achieving precise and potent induction ferroptosis in cancer cells with massive amplification of cellular lipid peroxidation and iron overloading, remains a significant hurdle. Herein, we developed a biomimetic red blood cell membranes (RBCM) camouflaged β-lapachone (Lap) and hemin nanoassembly (LHNPs@RBCM) as ferroptosis inducer for hepatocellular carcinoma (HCC) therapy. The RBCM endowed the nanoassembly with prolonged systemic circulation and improved tumor accumulation. After endocytosis of LHNPs@RBCM by cancer cells, the cancer-specific overexpressed NAD(P)H: quinone oxidoreductase (NQO1) converted the released Lap to ROS (e.g. O2.− , H2O2) with good selectivity, while hemin reacted with H2O2 and turned the less reactive H2O2 into highly reactive hydroxyl radical (·OH) by Fenton reaction. These ·OH reacted with polyunsaturated fatty acids (PUFAs), triggering lethal lipid peroxides (LPO) and subsequent ferroptosis. Additionally, the ROS induced activation of the NRF2 pathway, which in turn upregulates NQO1 and heme oxygenase 1 (HO-1), creating a positive feedback loop that further elevates H2O2 levels and labile iron pools. Due to the combination of classical GPX4 suppression pathway by ROS with a non-classical HO-1-mediated iron overload mechanism for ferroptosis, the LHNPs@RBCM effectively killed cancer cells in both cellular and animal models. The excellent therapeutic effect of LHNPs@RBCM demonstrated it as a transformative strategy for clinical ferroptosis-based therapy.  \n†Jiyue Wang and Yongyi Liang contributed equally as the joint first authors.  \n*Correspondence: Xiaolong Liu [xiaoloong.liu@gmail.com](xiaoloong.liu@gmail.com)[ ](xiaoloong.liu@gmail.com)Yao Huang [huangyao8055@163.com](huangyao8055@163.com)[ ](huangyao8055@163.com)Jingfeng Liu [drjingfeng@126.com](drjingfeng@126.com)[ ](drjingfeng@126.com)Xiaolong Zhang [xiaolongdo@gmail.com](xiaolongdo@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nWang et al. Journal of Nanobiotechnology (2026) 24:567 Page 2 of 15  \nKeywords Lip","cbCaio2gRnnWzgaP","https://ap.wps.com/l/cbCaio2gRnnWzgaP","pdf",4506101,15,"English","# Abstract\n# Introduction\n## Ferroptosis and therapeutic rationale\n## Clinical context in hepatocellular carcinoma\n## Classical vs non-classical ferroptosis models","[{\"question\":\"What problem does the study address in ferroptosis-based cancer therapy?\",\"answer\":\"It addresses the difficulty of achieving precise, potent ferroptosis induction with strong amplification of cellular lipid peroxidation and iron overload in cancer cells, which remains a significant hurdle.\"},{\"question\":\"How does the RBCM-camouflaged LHNPs@RBCM promote ferroptosis in hepatocellular carcinoma cells?\",\"answer\":\"After endocytosis, NQO1 converts released β-lapachone into ROS with selectivity, hemin uses H2O2 to generate hydroxyl radicals via Fenton reaction, and ROS then trigger lethal lipid peroxidation leading to ferroptosis.\"},{\"question\":\"What role does the NRF2 pathway play in amplifying ferroptosis?\",\"answer\":\"ROS activates NRF2, which upregulates NQO1 and HO-1, forming a positive feedback loop that elevates H2O2 levels and labile iron pools, further strengthening ferroptosis.\"}]","Biomimetic β-lapachone and hemin nanoassembly for intracellular oxidation cascade amplified ferroptosis in hepatocellular carcinoma therapy | PDF",1790129412,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd24df2349fbeb6832f72a38052d4b70.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6cc26ecd5c25eeb704f11e281d6d1a3.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b06573940235dc83c135772cf5387eb.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16ca341c3101f454e5d6ed55e9b5af43.webp",980,1306]